As planned in the protocol design ,  patients on the 5-FU and MeCCNU arm were treated for a longer duration than patients who received escalating 5-FU (median ,  11.3 months v 7.5 months ,  respectively) .
A recent National Institutes of Health consensus conference on adjuvant therapy for patients with colon and rectal cancer concluded that combined postoperative chemotherapy and radiation therapy improved local control and survival in stage B2 and C patients with rectal cancer and that treatment with combined modality therapy in these patients is recommended .
